SCHEMBL23009103

SCHEMBL23009103

C=CCCCc1ccc(C)cc1N(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.36
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
DRD2 P14416 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR1E P28566 1/20 0.33
SLC6A4 P31645 1/20 0.33
HTR7 P34969 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
ADRA1B P35368 1/20 0.33
DRD3 P35462 1/20 0.33
OPRK1 P41145 1/20 0.33
HTR2B P41595 1/20 0.33
HTR5A P47898 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12802432 0.80 TLR8 (0.40) TLR8HTR1AADRA2ADRD2ADRA2B
SCHEMBL23653456 0.80 GABRA1 (0.37) HTR1AADRA2ADRD2ADRA2BADRA2C
SCHEMBL19658157 0.78 TLR8 (0.42) TLR8USP2ALDH1A1HPGDTDP1
SCHEMBL12802144 0.76 TAAR1 (0.53) TLR8HTR1AADRA2ADRD2ADRA2B
SCHEMBL2970934 0.75 TAAR1 (0.41) TLR8HTR1AADRA2ADRD2ADRA2B
SCHEMBL8985363 0.75 TAAR1 (0.52) TLR8HTR1AADRA2ADRD2ADRA2B
SCHEMBL2984041 0.74 SRC (0.51) TLR8HTR1AADRA2ADRD2ADRA2B
SCHEMBL23008754 0.73 TYR (0.38) TLR8SLC6A4OPRK1SIGMAR1TDP1
SCHEMBL23008840 0.73 TLR8 (0.35) TLR8HTR6USP2ALDH1A1HPGD
SCHEMBL23008863 0.73 TYR (0.37) HTR1AADRA2ADRD2ADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021029632-A1 FUSED RING HETEROARYL COMPOUNDS AS RIPK1 INHIBITORS BISICHEM CO., LTD. (KR) 2021-02-18 WO disclosed